Pharmaceuticals
Company Overview of Symphony Evolution, Inc.
Key Executives for Symphony Evolution, Inc.
| Name | Board Relationships | Title | Age |
| Charles W. Finn Ph.D. | 27 Relationships | Chief Executive Officer | -- |
| Daniel R. Salins CPA | No Relationships | Chief Financial Officer | -- |
| Frank Hurley Ph.D. | 50 Relationships | Chief Scientific Officer | -- |
Symphony Evolution, Inc. Board Members*
| Name | Board Relationships | Primary Company | Age |
| Harri V. Taranto | 7 Relationships | Symphony Capital LLC | -- |
| Herbert J. Conrad M.S | 57 Relationships | Quill Medical Inc. | 79 |
| Daniel F. Hoth M.D. | 39 Relationships | Semafore Pharmaceuticals, Inc. | 66 |
| George A. Scangos Ph.D. | 124 Relationships | Biogen Idec Inc. | 64 |
| Alastair J. J. Wood M.D. | 22 Relationships | Symphony Capital LLC | 65 |
Symphony Evolution, Inc. Executive Committees*
| Committee Name | Chairperson | Board Relationships | Members | |
| There is no committee data available. | ||||
CEO COMPENSATION IN THIS INDUSTRY
| Industry Range | ||
| Salary | 408.2K | |
| Bonus | 478.9K | |
| Total Short Term Compensation | 560.0K | |
| Total Value of Options | 10.6M |
INDUSTRY EXECUTIVE CHANGES
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Riverside, CA | RecruitarrowPosted: May 22
- Souderton, PA | Hire IT PeoplePosted: May 22
- Cambridge, MA | RandstadPosted: May 22
Sponsored Financial Commentaries
Sponsored Links
To contact Symphony Evolution, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








